Rising pharmaceutical innovation in the Global South: a landscape study

References

• Akkari ACS, Munhoz IP, Tomioka J, Santos NMBF, Santos RFDPharmaceutical innovation: differences between Europe, USA and ‘pharmerging’ CountriesGest Prod201623365380 10.1590/0104-530X2150-15
   Google Scholar
• Andia T, Alfonso Pineda S, Gomez JS, Vargas MG, Castro C. Colombian health innovation landscape: Building Bridges. Universidad de los Andes; 2023.
   Google Scholar
• Bower DJ, Sulej JCThe Indian challenge: the evolution of a successful new global strategy in the pharmaceutical industryTechnol Anal Strateg Manag2007195611624 10.1080/09537320701521358
   Web of Science ®Google Scholar
• Casty FE, Wieman MSDrug development in the 21st century: the synergy of public, private, and international collaborationTher Innov Regul Sci2013473375383 10.1177/2168479013480787 30231429
   PubMed Web of Science ®Google Scholar
• Centro de pensamiento Medicamentos, información y poder. Innovación con enfoque en salud pública - Informe final y portafolio de casos. 2019. http://pensamiento.unal.edu.co/fileadmin/recursos/focos/medicamentos/docs/Informe_final.pdf. Accessed 18 May 2023.
   Google Scholar
• Chataway J, Tait J, Wield DFrameworks for pharmaceutical innovation in developing countries - the case of Indian PharmaTechnol Anal Strateg Manag2007195697708 10.1080/09537320701521465
   Web of Science ®Google Scholar
• Chaudhuri S. Evolution of the pharmaceutical industry Bangladesh, 1982 to 2020. SSRN Journal. 2020. https://www.ssrn.com/abstract=3767822. Accessed 18 May 2023.
   Google Scholar
• Creswell JW, Creswell JDResearch design: qualitative, quantitative, and mixed methods approaches20185Los AngelesSAGE
   Google Scholar
• Differding EThe drug discovery and development industry in india—two decades of proprietary small-molecule R&DChemMedChem20171211786818 1:CAS:528:DC%2BC2sXptVWlsL8%3D 10.1002/cmdc.201700043 28464443 5488177
   PubMed Web of Science ®Google Scholar
• Ding J, Xue Y, Liang H, Shao R, Chen YFrom imitation to innovation: a study of China’s Drug R&D and relevant national policiesJ Technol Manag Innov201162113 10.4067/S0718-27242011000200001
   Google Scholar
• DNDi. Anfoleish (CL). 2016. https://dndi.org/research-development/portfolio/anfoleish-cl/. Accessed 18 May 2023.
   Google Scholar
• Edwin JJ. Access to Medicines as a Right to Health, and the Conflict between Innovators and Generics: with a Focus on India as the “Pharmacy of the Developing World”. 2012. https://open.library.ubc.ca/soa/cIRcle/collections/graduateresearch/42591/items/1.0086026. Accessed 13 Oct 2021.
   Google Scholar
• Frew SE, Liu VY, Singer PAA business plan to help the ‘global south’ in its fight against neglected diseasesHealth Aff200928617601773 10.1377/hlthaff.28.6.1760
   PubMed Web of Science ®Google Scholar
• Gomez C. Regulation to accelerate access to biosimilars: Colombia’s pioneering approach. Knowledge Network on Innovation and Access to Medicines Webinar Series. 2019. https://www.graduateinstitute.ch/communications/events/regulation-accelerate-access-biosimilars-colombias-pioneering-approach. Accessed 18 May 2023.
   Google Scholar
• IDEA Pharma. Pharmaceutical innovation and invention index 2022. p. 21. IDEA Pharma. 2022. https://www.ideapharma.com. Accessed 27 Mar 2023.
   Google Scholar
• IFPMA. IFPMA facts and figures report. IFPMA. 2017. https://www.ifpma.org/resource-centre/ifpma-facts-and-figures-report/. Accessed 20 Oct 2021.
   Google Scholar
• Karim O, Srishti SA, Naher N, Ahmed SMPharmaceuticals research and development (R&D) in Bangladesh: ground realities and prospects2023DhakaBRAC James P Grant School of Public Health, BRAC University
   Google Scholar
• Khan T, Abimbola S, Kyobutungi C, Pai MHow we classify countries and people—and why it mattersBMJ Glob Health.202276e009704 10.1136/bmjgh-2022-009704 35672117 9185389
   PubMed Web of Science ®Google Scholar
• Liu Y, Vieira M. Clinical trials analysis results. Rising pharmaceutical innovation in the Global South. Zenodo. 2023a. https://zenodo.org/record/7802113. Accessed 1 Jun 2023.
   Google Scholar
• Liu Y, Vieira M. Clinical Trials_Original dataset. Rising Pharmaceutical Innovation in the Global South. Zenodo. 2023b. https://zenodo.org/record/7801929. Accessed 1 Jun 2023.
   Google Scholar
• López L, Vélez I, Asela C, Cruz C, Alves F, Robledo S, et al.A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in ColombiaPLoS Negl Trop Dis2018127e0006653 1:CAS:528:DC%2BC1MXhs1OrurbO 10.1371/journal.pntd.0006653 30044792 6078324
   PubMed Web of Science ®Google Scholar
• Merson L, Ndwandwe D, Malinga T, Paparella G, Oneil K, Karam G, et al. ICTRP analysis dataset.xlsx. Harvard Dataverse. 2022a. https://dataverse.harvard.edu/file.xhtml?persistentId=doi:10.7910/DVN/2ZNIFV/7VPHAR. Accessed 30 Oct 2022.
   Google Scholar
• Merson L, Ndwandwe D, Malinga T, Paparella G, Oneil K, Karam G, et al.Promotion of data sharing needs more than an emergency: an analysis of trends across clinical trials registered on the International Clinical Trials Registry PlatformWellcome Open Res20227101 10.12688/wellcomeopenres.17700.1 35419494 8980676
   PubMedGoogle Scholar
• Moncayo Jiménez ELas políticas regionales de ciencia, tecnología e innovación en Colombia: surgimiento, evolución y balance de la situación actualOPE2018 10.18601/16578651.n23.11
   Google Scholar
• Moon S, Vieira M, Alonso Ruiz A, Navarro D. New business models for pharmaceutical research and development as a global public good: considerations for the WHO European Region. Copenhagen: WHO Regional Office for Europe. (Oslo Medicines Initiative technical report). 2022. https://apps.who.int/iris/handle/10665/361752. Accessed 22 Jan 2023.
   Google Scholar
• Observatorio Colombiano de Ciencia y Tecnología - OCyT. Informe de Indicadores de Ciencia, Tecnología e Innovación en Colombia 2020. 2020. https://indicadoresctei2020.ocyt.org.co/Informe%20Indicadores%20CTeI%202020%20v1.pdf. Accessed 18 May 2023.
   Google Scholar
• Observatorio Colombiano de Ciencia y Tecnología - OCyT. Informe de Indicadores de Ciencia, Tecnología e Innovación en Colombia 2021 (versión preliminar). 2021. https://ocyt.org.co/wp-content/uploads/2022/12/informe-indicadores-CTeI-2021-MA.pdf. Accessed 18 May 2023.
   Google Scholar
• Policy Cures Research. G-FINDER. n.d. https://www.policycuresresearch.org/g-finder/. Accessed 15 Oct 2022.
   Google Scholar
• Rezaie R, McGahan AM, Daar AS, Singer PAInnovative drugs and vaccines in China, India and BrazilNat Biotechnol20123010923926 1:CAS:528:DC%2BC38XhsVyjs7zE 10.1038/nbt.2380 23051806
   PubMed Web of Science ®Google Scholar
• Rezaie R, McGahan AM, Frew SE, Daar AS, Singer PAEmergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaboratorsHealth Res Policy Syst201210118 10.1186/1478-4505-10-18 22672351 3424104
   PubMedGoogle Scholar
• Røttingen JA, Regmi S, Eide M, Young AJ, Viergever RF, Årdal C, et al.Mapping of available health research and development data: what’s there, what’s missing, and what role is there for a global observatory?Lancet2013382990012861307 10.1016/S0140-6736(13)61046-6 23697824
   PubMed Web of Science ®Google Scholar
• Royhan PMarket access challenges and opportunities for Bangladesh pharmaceutical products under TRIPSJ Intellect Prop Law Pract2013812932938 10.1093/jiplp/jpt191
   Google Scholar
• Sectorial. Huella económica y sostenibilidad financeira indústria farmacêutica em Colombia. 2022. https://www.midato.co/informe-huella-economica-y-sostenibilidad/. Accessed 22 June 2023.
   Google Scholar
• Thomas B, Chugan PK, Srivastava D. Pharmaceutical Research and Licensing Deals in India. Rochester, NY: Social Science Research Network. Report No.: ID 2761728. 2016 Jan. https://papers.ssrn.com/abstract=2761728. Accessed 18 May 2023.
   Google Scholar
• U.S. Department of Health and Human Services, National Institutes of Health, National Library of Medicine, and National Center for Biotechnology Information. ClinicalTrials.gov. https://clinicaltrials.gov/. Accessed 7 July 2023.
   Google Scholar
• Vasconcellos AG, de Fonseca e Fonseca BP, Morel CMRevisiting the concept of Innovative Developing Countries (IDCs) for its relevance to health innovation and neglected tropical diseases and for the prevention and control of epidemicsPLoS Negl Trop Dis2018127e0006469 10.1371/journal.pntd.0006469 30001318 6042684
   PubMed Web of Science ®Google Scholar
• Vidotti CCF, de Castro LLC, Calil SSNew drugs in Brazil: do they meet Brazilian public health needs?Rev Panam Salud Publica20082413645 10.1590/S1020-49892008000700005 18764993
   PubMed Web of Science ®Google Scholar
• Vieira M, Alonso Ruiz A. Covid-19 ‘vaccine apartheid’: why local production must be strengthened. Swissinfo. 2021 May 26. https://www.swissinfo.ch/eng/covid-19--vaccine-apartheid---why-local-production-must-be-strengthened/46648820. Accessed 18 May 2023.
   Google Scholar
• Vieira M, Liu Y, Siddiqui A, Ruiz AA, Large KE, Moon S, editors. Rising pharmaceutical innovation in the Global South: painting with new colors. Graduate Institute of International and Development Studies, Global Health Centre. 2023. https://repository.graduateinstitute.ch/record/301401. Accessed 18 May 2023.
   Google Scholar
• Viergever RF, Hendriks TCCThe 10 largest public and philanthropic funders of health research in the world: what they fund and how they distribute their fundsHealth Res Policy Sys201614112 10.1186/s12961-015-0074-z
   PubMedGoogle Scholar
• Weng HB, Chen HX, Wang MWInnovation in neglected tropical disease drug discovery and developmentInfect Dis Poverty20187167 10.1186/s40249-018-0444-1 29950174 6022351
   PubMed Web of Science ®Google Scholar
• WHO. International Clinical Trials Registry Platform (ICTRP). who.int. 2022. https://www.who.int/clinical-trials-registry-platform. Accessed 14 Dec 2022.
   Google Scholar
• WHO Global Observatory on Health R&D. Gross domestic R&D expenditure on health (health GERD) as a % of GDP [Internet]. who.int. 2021. https://www.who.int/observatories/global-observatory-on-health-research-and-development/indicators/gross-domestic-r-d-expenditure-on-health-as-a-percent-of-gross-domestic-product. Accessed 10 Mar 2023.
   Google Scholar
• WHO Global Observatory on Health R&D. Health researchers (in full-time equivalent) per million inhabitants, by income group. who.int. 2021b. https://www.who.int/observatories/global-observatory-on-health-research-and-development/indicators/health-researchers-in-full-time-equivalent-per-million-inhabitants-by-income-group-second-set-of-charts. Accessed 15 Jan 2022.
   Google Scholar
• World Health Organization. Global Observatory on Health Research and Development. https://www.who.int/observatories/global-observatory-on-health-research-and-development. Accessed 15 Jan 2022.
   Google Scholar
• World RePORT. World RePORT: International biomedical research organization support. worldreport.nih.gov. n.d. https://worldreport.nih.gov/. Accessed 10 Oct 2022.
   Google Scholar